Research prototype, not medical advice.

In a small randomized crossover trial (20 people aged 60-79), MitoQ improved vascular function.

Confidence
Debated
Level of evidence
Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Mitochondrial dysfunctionMitoQ (mitochondria-targeted antioxidant)Reactive oxygen species (ROS)

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults
Rossman et al. · Hypertension 2018
— Verified

Related claims